The company in question is, Radius Health, Inc. (NASDAQ:RDUS) currently with a stock price of 52.13 (-0.65% today). The market cap for Radius Health, Inc. is 2281.4, and is in the sector Healthcare, and Biotechnology industry. The target price for Radius Health, Inc. is 60.38. Currently Radius Health, Inc. is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for Radius Health, Inc. is 1016.13 and so far today it is 279325.
Performance in the last year for Radius Health, Inc. has been -3.10%. For EPS growth, Radius Health, Inc. has seen a growth of 36.60%, and is looking to grow in the next year to 10.60%. More long term stats show that EPS growth has been -19.90% over the last five years and could be 3.00% for the next five years. Radius Health, Inc. has seen sales growth quarter over quarter at *TBA, with EPS growth quarter over quarter at -66.50%. The 20-day simple moving average is -4.79%, with the 200-day simple moving average coming to 26.85%.
Since the IPO date for Radius Health, Inc. on the 06/06/2014, Radius Health, Inc. has seen performance year to date to be -14.74%. With Radius Health, Inc. trading at 52.13, the dividend yield is *TBA, and the EPS is -3.41.
So could Radius Health, Inc., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is *TBA and the P/B is at 5.79. The P/cash is 5.69, with P/free cash flow at *TBA.
Radius Health, Inc. ability to deal with debt shows that the current ratio is 20.7, and the quick ratio is 20.7. This is with long term debt/equity at 0, and total debt/equity at 0.
In terms of margins, Radius Health, Inc. has a gross margin of *TBA, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Radius Health, Inc. is *TBA. Return on assets come to -31.50% with return on investment coming to *TBA.
Insider ownership for Radius Health, Inc., is at 26.28% and institutional ownership comes to 65.90%. Outstanding shares are at 43.48. While shares float is 36.34. The float short is currently 20.49%, and short ratio is 7.33.